Antimigren (sumatriptan) tablets 100 mg. №1

$8.00

Manufacturer: Ukraine

Purpose: Blocks release of substances causing inflammation and pain in migraines.

SKU: MED56513 Category:

Description

Antimigren (Sumatriptan) Tablets 100 mg. №1

Composition

Active ingredient: Sumatriptan succinate 100 mg.

Mechanism of Action

Pharmacological Properties: Sumatriptan, a selective 5-HT1 receptor agonist, exerts vasoconstrictive effects by narrowing blood vessels in the brain. This action helps alleviate migraine headaches by inhibiting the release of inflammatory neuropeptides associated with migraine symptoms.

Indications for Use

Indications: Antimigren tablets are indicated for the acute treatment of migraine attacks with or without aura.

Contraindications

Contraindications: Avoid Antimigren use if you have uncontrolled hypertension, ischemic heart disease, or a history of stroke.

Side Effects

Side Effects: Common side effects may include dizziness, drowsiness, tingling sensations, and mild chest discomfort. Serious side effects are rare but may include chest pain, changes in heart rate, or signs of a stroke.

Usage Instructions

Directions: Take one tablet (100 mg) orally with water at the onset of migraine symptoms. A second dose may be taken after 2 hours if needed, but do not exceed 200 mg in a 24-hour period.

Benefits Compared to Analogues

Benefits: Antimigren tablets offer rapid and sustained relief from migraine pain and associated symptoms, such as nausea and sensitivity to light and sound, making them effective for acute migraine management compared to other treatments.

Suitable Patient Groups

Suitable Patients: Antimigren tablets are suitable for adults experiencing acute migraine attacks. Special caution is advised when considering use in elderly patients or individuals with underlying cardiovascular conditions.

Storage and Shelf Life

Storage: Keep Antimigren tablets in their original packaging at room temperature, away from moisture and sunlight. Check the expiration date and do not use expired medication.

Packaging Description

Packaging: Antimigren tablets are typically packed in blister packs to ensure individual tablet protection and ease of use. Each pack contains a specific number of tablets as indicated on the packaging.

Clinical Evidence and Proven Effectiveness

Clinical Evidence: Sumatriptan, the active ingredient in Antimigren tablets, has been extensively studied for its efficacy in relieving migraine pain and associated symptoms. Clinical trials have demonstrated that Antimigren tablets provide significant relief within 2 hours of administration, reducing headache severity and the need for rescue medications compared to placebo.